CCN2 and neoplasm: The decrease of tumor IFP by losartan was associated with reduction of stromal collagen and hyaluronan production, a decrease in the expression of profibrotic signals transforming growth factor (TGF)-β1, connective tissue growth factor (CCN2) and endothelin-1 (ET-1) 10.